Commodities Week Ahead: Gold, Oil Hunt For Clues From Fed, Virus Solutions

 | Aug 24, 2020 10:07

President Donald Trump’s politically well-timed announcement of a blood plasma treatment option for the coronavirus has lifted stock markets and bought the dollar some reprieve ahead of a dour evaluation of the US economy expected from the Federal Reserve this week. The net outcome for gold and oil investors, however, is a little more uncertainty. 

Prices of the shiny metal and crude were slightly lower in Asia as trading for the new week began amid the US Food & Drug Administration’s “emergency use authorization” of blood plasma from recovered patients as a treatment option for COVID-19.  

The announcement came on the eve of the Republican National Convention, where Trump will be nominated to lead his party for four more years. The president last week accused “deep state” elements within the FDA of trying to delay progress on vaccines and therapeutics until after November 3rd, US Election Day. 

h2 Risk Aversion Still On The Table /h2

The Trump administration is also considering by-passing normal US regulatory standards to fast-track an experimental coronavirus vaccine from the UK for use in America ahead of the election, the Financial Times reported. Still, European hotspots for the virus saw new spikes last week, with Spain having 6,671 cases, France 3,776 and Germany over 1,500—all the most in a day, on Wednesday.  

“The authorized emergency use of convalescent plasma could be considered as the latest push to the commodity bears,” said Anil Panchal at FX Street.

“However, the strong bounce-back of the virus in Germany, France and Spain keeps the risk aversion on the table.”

 Benchmark December gold futures on New York’s Comex was down $6.60, or 0.3%, at $1,940.40 per ounce by 5:30 GMT.